bromocriptine has been researched along with Cirrhosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, Q; Hu, B; Jiang, X; Mao, Z; Wang, H; Wang, X; Wang, Z; Xiao, Z; Zhu, D; Zhu, Y | 1 |
Andersohn, F; Garbe, E | 1 |
Elenkova, A; Kalinov, K; Shabani, R; Zacharieva, S | 1 |
Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P | 1 |
Benard, A; Guenanen, H; Tillie-Leblond, I; Wallaert, B | 1 |
1 review(s) available for bromocriptine and Cirrhosis
Article | Year |
---|---|
[Drug-induced pleurisy].
Topics: Bromocriptine; Dantrolene; Dopamine Agonists; Ergotamines; Fibrosis; Humans; Muscle Relaxants, Central; Pleura; Pleural Diseases; Pleural Effusion; Pleurisy | 1996 |
4 other study(ies) available for bromocriptine and Cirrhosis
Article | Year |
---|---|
miR-93-5p targets Smad7 to regulate the transforming growth factor-β1/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma.
Topics: Adult; Bromocriptine; Drug Resistance, Neoplasm; Female; Fibrosis; Humans; Male; MicroRNAs; Middle Aged; Pituitary Neoplasms; Prolactinoma; Signal Transduction; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta1; Up-Regulation | 2019 |
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States | 2009 |
Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Prolactinoma; Prospective Studies | 2012 |
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2004 |